| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/11/2008 | US20080219947 Single chain trimers and uses therefor |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967594A2 Detection of nucleic acids by type-specific hybrid capture method |
| 09/10/2008 | EP1967592A1 Method of improving the efficiency of polynucleotide sequencing |
| 09/10/2008 | EP1965827A2 Treatment of conditions involving demyelination |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1401851B8 Two-stage protective groups for the synthesis of biopolymers |
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1012156B1 Nucleic acid sequences and method for isolating bacteries from the type genus pseudomonas aeruginosa |
| 09/10/2008 | EP0832245B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 09/10/2008 | CN101260401A Gene encoding a marker for cancer |
| 09/10/2008 | CN101260148A Hybrid and tandem expression of neisserial proteins |
| 09/10/2008 | CN101259289A Methods and compositions for therapeutic use of RNA interference |
| 09/10/2008 | CN100417664C Interleukin-17 acceptor, and its coding gene and application |
| 09/09/2008 | USRE40494 Using chromosomal material and a unique sequence high complexity nucleic acid probe of greater than about 50,000 bases in in situ hybridization, wherein the chromosomal material is present in a morphologically identifiable cell nucleus; allowing probe to bind to targeted chromosomal material |
| 09/09/2008 | US7423203 Expression vector comprising nucleotide sequences coding fungal hexokinase for as tool in enhancing carbon sequestration within plant seeds |
| 09/09/2008 | US7423196 Increased growth under water-limited conditions and/or increased tolerance to an environmental stress as compared to a wild type variety of the plant; drought-tolerant |
| 09/09/2008 | US7423143 Coupling via incubating with transferase; solid phase synthesis |
| 09/09/2008 | US7423142 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent |
| 09/09/2008 | US7423141 Inhibitors of endothelin-1 synthesis |
| 09/09/2008 | US7423140 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing |
| 09/09/2008 | US7423139 Expresion vector comprising nucleotide sequences coding secreted glycoprotein hormone with modified untranslated region for use in enhancement of blood production; directed protein evolution |
| 09/09/2008 | US7423137 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 09/09/2008 | US7423136 Fermentation using genetically engineered microorganisms, including Escherichia coli and Pseudomonas mutabilis, and DNA sequences and vectors; biosynthesis |
| 09/09/2008 | US7423135 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 09/09/2008 | US7423133 Fluorescent glycosides and methods for their use |
| 09/09/2008 | US7423130 A nucleic acid sequence encoding the polypeptide, lacking its associated signal peptide |
| 09/09/2008 | US7423120 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/09/2008 | US7422902 Nucleic acid encapsulated in cationic lipid, e.g., dimethyldioleoylammonium chloride, non-cationic lipid, e.g., palmitoyl oleoyl phosphatidylcholine, and polyethylene glycol-conjugated lipid that inhibits aggregations of particles; resistant in aqueous solution to degradation with a nuclease |
| 09/09/2008 | US7422896 Compositions for DNA mediated gene silencing |
| 09/09/2008 | US7422890 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 09/09/2008 | US7422888 Improved heat resistance; genetic engineering |
| 09/09/2008 | US7422887 Phospholipase A2 and gene thereof |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422884 Especially feedback inhibition by farnesyl diphosphate or geranylgeranyl diphosphate; producing isoprenoid compounds, particularly coenzyme Q10 |
| 09/09/2008 | US7422881 From snapdragon or torenia plants, for altering flower color; gene expression inhibition |
| 09/09/2008 | US7422876 Methods for generating cellulases |
| 09/09/2008 | US7422873 Mutant carotenoid ketolase |
| 09/09/2008 | US7422853 RNA interference using a universal target |
| 09/09/2008 | US7422847 Human E3α ubiquitin ligase family |
| 09/09/2008 | US7422754 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 09/09/2008 | US7422747 Transgenic plant-based vaccines |
| 09/09/2008 | CA2622649A1 Primer, primer set, and nucleic acid amplification method and mutation detection method using the same |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/04/2008 | WO2008106175A2 Gene and protein expression profiles associated with the therapeutic efficacy of egfr-tk inhibitors |
| 09/04/2008 | WO2008106102A2 Inhibitors of rtp801 and their use in disease treatment |
| 09/04/2008 | WO2008105886A2 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 09/04/2008 | WO2008105792A2 Methods for depositing nanomaterial, methods for fabricating a device, methods for fabricating an array of devices and compositions |
| 09/04/2008 | WO2008088863A3 Stem cell gene targeting |
| 09/04/2008 | WO2008077600B1 Compounds and methods for synthesis and purification of oligonucleotides |
| 09/04/2008 | WO2008073165A3 Methods and compositions for identifying anti-hcv agents |
| 09/04/2008 | WO2008061048A3 Methods and compositions for diagnosing and treating prostate cancer |
| 09/04/2008 | WO2008042762A3 Single nucleotide polymorphisms associated with cardiovascular disease |
| 09/04/2008 | WO2007147067A3 Methods and compositions for regulating cell cycle progression |
| 09/04/2008 | WO2007139926A3 Crac channel and modulator screening methods |
| 09/04/2008 | WO2007130962A3 Diagnosis of cardiovascular disease |
| 09/04/2008 | WO2007109582A3 Method of treating pulmonary edema or pulmonary inflammation |
| 09/04/2008 | WO2007098279A3 Analyte detection using barcoded polymers |
| 09/04/2008 | US20080216199 removing molybdenum from a molybdenum-containing soil environment by growing a transgenic plant having a molybdenum transporter activity |
| 09/04/2008 | US20080216197 Pyridoxine biosynthetic protein for use in identifying agents which suppess growth of plants |
| 09/04/2008 | US20080216193 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 09/04/2008 | US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 09/04/2008 | US20080214799 Fetal gene expression network/profile for identifying gene products which confer apoptosis resistant and interleukin-6 repressive phenotypes; treating and/or preventing ischemic reperfusion injuries |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214783 Method of Synthesizing Protein, mRna Immobilized on Solid Phase and Apparatus for Synthesizing Protein |
| 09/04/2008 | US20080214667 Nucleic acid molecule; complementary to a nucleotide sequence encoding a polypeptide having elongase activity |
| 09/04/2008 | US20080214494 Method of drug delivery by carbon nanotube-chitosan nanocomplexes |
| 09/04/2008 | US20080214490 Administering purinergic receptor agonist P1, P4-di(uridine 5'-) tetraphosphate for secretion stimulation; vaginal dryness associated with menopause, chemotherapy, and various disease states as well as the treatment of vulvar pain |
| 09/04/2008 | US20080214486 RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 09/04/2008 | US20080214484 Nucleic acids encoding sarcocystis neurona antigen and uses thereof |
| 09/04/2008 | US20080214483 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 09/04/2008 | US20080214468 Administering a peptide, identified through a phage display library; osteogenesis, cell adhesion/angiogenesis, inhibiting cancer cell metastasis |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214437 RNA interference; gene therapy; inhalers |
| 09/04/2008 | US20080214436 Methods and compositions for the treatment of cancer or other diseases |
| 09/04/2008 | US20080214412 Method and device for preparing and/or analyzing biochemical reaction carriers |
| 09/04/2008 | US20080213917 Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits |
| 09/04/2008 | US20080213891 RNAi Agents Comprising Universal Nucleobases |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213872 Removable flow-through body containing two ends, filter and nucleic acid binding surface for use in extraction of nucleic acids from parasites and cells |
| 09/04/2008 | US20080213852 Nucleotide sequences coding sugar transporter and/or sugar alcohol transporter for use in enhanced fermentation of vitamin c |
| 09/04/2008 | US20080213843 Heat stable glycoamylase for use in producing ethanol for fuel and/or beverages; sweetener production |
| 09/04/2008 | US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213835 Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same |
| 09/04/2008 | US20080213834 Gsk3 ligands and polynucleotides encoding gsk3 ligands |
| 09/04/2008 | US20080213833 Methods for Obtaining Optically Active Glycidyl Ethers and Optically Active Vicinal Diols from Racemic Substrates |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213830 Modified botulinum toxin comprising translocation, enzymatic and binding domains for use in cosmetics and treatment of pain disorders |
| 09/04/2008 | US20080213824 Fluorescence in situ hybridization staining employing an aqueous acetonitrile/dimethylsulfoxide mixture in fluorophore coupling reaction |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213791 Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer |
| 09/04/2008 | US20080213784 Screening methods and sequences relating thereto |
| 09/04/2008 | US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders |
| 09/04/2008 | US20080213774 Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors |